Kohli, S.; Philip, A.; Sarpong-Mensah, P.; Akande, Y.; Sheikh, I.-M.I.; George, L.; Agrohi, J.; Mutneja, H.
Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes: A Propensity-Matched Study. Gastroenterol. Insights 2026, 17, 38.
https://doi.org/10.3390/gastroent17020038
AMA Style
Kohli S, Philip A, Sarpong-Mensah P, Akande Y, Sheikh I-MI, George L, Agrohi J, Mutneja H.
Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes: A Propensity-Matched Study. Gastroenterology Insights. 2026; 17(2):38.
https://doi.org/10.3390/gastroent17020038
Chicago/Turabian Style
Kohli, Saksham, Anil Philip, Philip Sarpong-Mensah, Yetunde Akande, Ibrahimkhalil-Mohamud Ibrahim Sheikh, Lina George, Jhalak Agrohi, and Hemant Mutneja.
2026. "Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes: A Propensity-Matched Study" Gastroenterology Insights 17, no. 2: 38.
https://doi.org/10.3390/gastroent17020038
APA Style
Kohli, S., Philip, A., Sarpong-Mensah, P., Akande, Y., Sheikh, I.-M. I., George, L., Agrohi, J., & Mutneja, H.
(2026). Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes: A Propensity-Matched Study. Gastroenterology Insights, 17(2), 38.
https://doi.org/10.3390/gastroent17020038
